drugset / Trial / NCT01033747
Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and the effects on liver iron of Deferasirox when given for a long treatment period in patients with transfusion dependent iron overload.
Timeline
- Start
- 2003-02
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferasirox | Unknown | 5 mg/kg | Oral |
| Subject | Deferasirox | Unknown | 10 mg/kg | Oral |
| Subject | Deferasirox | Unknown | 30 mg/kg | Oral |